A Closer Look at Pegloticase Treatment in Gout

Rheum Advisor on Air
10/12/2020 10 min Temporada 1 Episodio 10
A Closer Look at Pegloticase Treatment in Gout

Listen "A Closer Look at Pegloticase Treatment in Gout"

Descargar episodio Ver en sitio original

Episode Synopsis

Approved by the US Food and Drug Administration for the treatment of refractory gout, pegloticase, in combination with immunomodulatory agents, is an area of gout treatment that has shown much promise.  Our featured guest on this episode is Brian LaMoreaux, MD, MS, an investigator on many gout studies, who provides an overview of the notable research in pegloticase treatment in gout, as presented at the American College of Rheumatology (ACR) 2020 annual meeting.

More episodes of the podcast Rheum Advisor on Air

Gout Management at the Intersection of Primary Care and Rheumatology 21/06/2023
Sleep Disorders in Rheumatic Diseases: A Wake-Up Call 20/04/2023
A Shot in the Arm: COVID-19 Vaccine Safety in Autoimmune Rheumatic Diseases 22/03/2023
COVID-19 Vaccine Hesitancy: What Your Patients Want You to Know 08/02/2023
Advancing Global Rheumatology Research – It Takes a Joint Effort 17/01/2023
Legal Considerations for Telemedicine Practice in a Post-Pandemic World 24/08/2022
Gout Among Women: Not Just a "Man's Disease" 20/05/2022
It's About Time We Took Chronic Pain Seriously 29/04/2022
The Elephant in the Rheum – "Burnout" Among the Workforce 24/03/2022
In Rare We Care: Pediatric Rheumatic Disease Awareness & Management 25/02/2022
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA